The product focuses on macular edema caused by retinal vein occlusion (RVO), an eye disease that puts about 7.4 million patients in China at risk of going blind.
If not treated in time, over 90 percent of the central retinal vein occlusion patients' final visual acuity will be lower than 0.1, causing blindness.
========================================================
部分内容来自网络，如有版权问题请与我们联系
未经许可，严禁转发。QQ交流群：688169419
========================================================